Effect of long-term co-administration of Wuzhi tablet (Schisandra sphenanthera extract) and prednisone on the pharmacokinetics of tacrolimus

Phytomedicine

Volumn 20, Issue 3-4, 2013, Pages 375-379

  Qin, Xiao Ling ^a   Yu, Tao ^a   Li, Ling Jue ^a   Wang, Ying ^a   Gu, Hao Min ^a   Wang, Yong Tao ^a   Huang, Min ^a   Bi, Hui Chang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Herb drug interaction; Pharmacokinetics; Prednisone; Schisandra sphenanthera extract; Tacrolimus

Indexed keywords

PLANT EXTRACT; PREDNISONE; SCHISANDRA SPHENANTHERA EXTRACT; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG EFFECT; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; RAT; SCHISANDRA; SCHISANDRA SPHENANTHERA; TABLET;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; DRUGS, CHINESE HERBAL; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; PHYTOTHERAPY; PREDNISONE; RATS; RATS, SPRAGUE-DAWLEY; SCHISANDRA; TACROLIMUS;

RATTUS; SCHISANDRA SPHENANTHERA;

EID: 84873739425     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2012.11.008     Document Type: Article

References (28)

1. D. Anglicheau, M. Flamant, M.H. Schlageter, F. Martinez, B. Cassinat, P. Beaune, C. Legendre, and E. Thervet Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation Nephrology Dialysis Transplantation 18 2003 2409 2414
2. L.J. Bowman, and D.C. Brennan The role of tacrolimus in renal transplantation Expert Opinion on Pharmacotherapy 9 2008 635 643
3. A. Crowe, and A.M. Tan Oral and inhaled corticosteroids: differences in P-glycoprotein (ABCB1) mediated efflux Toxicology and Applied Pharmacology 260 2012 294 302
4. R.Y. Chenhsu, C.C. Loong, M.H. Chou, M.F. Lin, and W.C. Yang Renal allograft dysfunction associated with rifampin-tacrolimus interaction Annals of Pharmacotherapy 34 2000 27 31
5. K. Dilger, M. Schwab, and M.F. Fromm Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein Inflammatory Bowel Diseases 10 2004 578 583
6. FDA, Drug interaction labeling. http://www.fda.gov/Drugs/ DevelopmentApproval Process/DevelopmentResources/DrugInteractionsLabeling/ ucm093664.htm - potency.
7. M.F. Hebert, J.M. Park, Y.L. Chen, S. Akhtar, and A.M. Larson Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers The Journal of Clinical Pharmacology 44 2004 89 94
8. C. Huyke, K. Engel, B. Simon-Haarhaus, K.-W. Quirin, and C.M. Schempp Composition and biological activity of different extracts from Schisandra sphenanthera and Schisandra chinensis Planta Medica 73 2007 1116 1126
9. K. Iwasaki Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics Drug Metabolism and Pharmacokinetics 22 2007 328 335
10. H. Iwata, Y. Tezuka, S. Kadota, A. Hiratsuka, and T. Watabe Identification and characterization of potent CYP3A4 inhibitors in Schisandra fruit extract Drug Metabolism and Disposition 32 2004 1351 1358
11. A. Jain, R. Kashyap, F. Dodson, D. Kramer, I. Hamad, A. Khan, B. Eghestad, T.E. Starzl, and J.J. Fung A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report Transplantation 72 2001 1091 1097
12. H. Jeong, and W.L. Chiou Role of P-glycoprotein in the hepatic metabolism of tacrolimus Xenobiotica 36 2006 1 13
13. B.S. Kalra Cytochrome P450 enzyme isoforms and their therapeutic implications: an update Indian Journal of Medical Science 61 2007 102 116
14. C. Liu, Y.-F. Shang, X.-F. Zhang, X.-G. Zhang, B. Wang, Z. Wu, X.-M. Liu, L. Yu, F. Ma, and Y. Lv Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study European Journal of Clinical Pharmacology 65 2009 881 885
15. W.T. Loo, M.N. Cheung, and L.W. Chow Fructus schisandrae (Wuweizi)-containing compound inhibits secretion of HBsAg and HBeAg in hepatocellular carcinoma cell line Biomedicine and Pharmacotherapy 61 2007 606 610
16. I. Mai, E. Stormer, S. Bauer, H. Kruger, K. Budde, and I. Roots Impact of St. John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients Nephrology Dialysis Transplantation 18 2003 819 822
17. R.M. Mentzer Jr., M.S. Jahania, and R.D. Lasley Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. The U. S. multicenter FK506 study group Transplantation 65 1998 109 113
18. S.I. Park, C.R. Felipe, P.G. Pinheiro-Machado, R. Garcia, F.B. Fernandes, D.E. Casarini, H. Tedesco-Silva Jr., and J.O. Medina-Pestana Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus Fundamental & Clinical Pharmacology 23 2009 137 145
19. L. Pichard, I. Fabre, M. Daujat, J. Domergue, H. Joyeux, and P. Maurel Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes Molecular Pharmacololgy 41 1992 1047 1055
20. P. Qiangrong, T. Wang, Q. Lu, and X. Hu Schisandrin B-a novel inhibitor of P-glycoprotein Biochemical and Biophysical Research Communications 335 2005 406 411
21. X.L. Qin, H.C. Bi, C.X. Wang, J.L. Li, X.D. Wang, L.S. Liu, X. Chen, and M. Huang Study of the effect of Wuzhi tablet (Schisandra sphenanthera extract) on tacrolimus tissue distribution in rat by liquid chromatography tandem mass spectrometry method Biomedical Chromatography 24 2010 399 405
22. X.L. Qin, H.C. Bi, X.D. Wang, J.L. Li, Y. Wang, X.P. Xue, X. Chen, C.X. Wang, L.J. Xu, Y.T. Wang, and M. Huang Mechanistic understanding of the different effects of Wuzhi tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK506) International Journal of Pharmaceutics 389 2010 114 121
23. R. Shapiro, M.L. Jordan, V.P. Scantlebury, C. Vivas, J.W. Marsh, J. McCauley, J. Johnston, P. Randhawa, W. Irish, H.A. Gritsch, R. Naraghi, T.R. Hakala, J.J. Fung, and T.E. Starzl A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients Transplantation 67 1999 411 415
24. C.E. Staatz, and S.E. Tett Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation Clinical Pharmacokinetics 43 2004 623 653
25. M. Sun, X. Xu, Q. Lu, Q. Pan, and X. Hu Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1 Cancer Letters 246 2007 300 307
26. R. Venkataramanan, A. Swaminathan, T. Prasad, A. Jain, S. Zuckerman, V. Warty, J. McMichael, J. Lever, G. Burckart, and T. Starzl Clinical pharmacokinetics of tacrolimus Clinical Pharmacology 29 1995 404 430
27. C.R. Yates, C. Chang, J.D. Kearbey, K. Yasuda, E.G. Schuetz, D.D. Miller, J.T. Dalton, and P.W. Swaan Structural determinants of P-glycoprotein-mediated transport of glucocorticoids Pharmceutical Research 20 2003 1794 1803
28. H.H. Yoo, M. Lee, M.W. Lee, S.Y. Lim, J. Shin, and D.H. Kim Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 Planta Medica 73 2007 444 450